C08B 35/04
Ethers
C08B35/04 (Ethers) appears on 13 US grants and 17 published applications in this corpus.
Search patents in C08B- Granted patents
- 13
- Published applications
- 17
- Assignees
- 10
- Inventors
- 30
- Latest grant
- 16 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 2 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 3 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Water-enriching and water depleting compositions and methods16 Nov 2021US 11,174,374 B2Dober Chemical Corporation
- Modified starch material of biocompatible hemostasis5 Feb 2019US 10,195,312 B2
- Modified starch material of biocompatible hemostasis18 Sep 2018US 10,076,590 B2
- Hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds5 Sep 2017US 9,751,866 B2ISP Investments Inc.
- Modified starch material of biocompatible hemostasis27 Jun 2017US 9,687,501 B2
- Water-Enriching and Water Depleting Compositions and Methods12 Dec 2019US 2019/0374877 A1Dober Chemical Corporation
- Modified starch material of biocompatible hemostasis15 Jun 2017US 2017/0165404 A1
- Modified starch material of biocompatible hemostasis18 May 2017US 2017/0136054 A1
- Modified Starch Material of Biocompatible Hemostasis24 Nov 2016US 2016/0339143 A1
- Hemi-aminal ethers and thioethers of n-alkenyl cyclic compounds3 Dec 2015US 2015/0344461 A1ISP Investments Inc.
Most cited
By later US patents
- Papermaking additives and mechanical pulp with primary amino groups17US 6,455,661 B1Pulp and Paper Research Institute of Canada · 2002
- Modified starch material of biocompatible hemostasis11US 8,575,132 B22013
- Stabilized or stabilized, crosslinked waxy potato starch10US 6,541,060 B2National Starch and Chemical Investment Holding Corporation · 2003
- Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate10US 7,115,576 B2Fresenius Kabi Deutschland GmbH · 2006
- Modified starch material of biocompatible hemostasis10US 8,912,168 B22014